BOPI 04 BR/2024 REPERTOIRE NUMERIQUE 43 Fig. 1 ________________________________________ (11) 21528 Consulter le mémoire (51) C07D 471/04 (2018.01); C07D 473/34 (2018.01) ; C07D 519/00 (2018.01) (21) 1201600499 - PCT/IB2015/054958 (22) 01/07/2015 (30) IN n° 2182/MUM/2014 du 04/07/2014 (54) Quinolizinone derivatives as PI3K inhibitors. (72) KULKARNI Sanjeev Anant (IN); KAMBOJ Rajender Kumar (IN); PALLE Venkata P. (IN); SHUKLA Manojkumar Ramprasad (IN); JANA Nirmal Kumar (IN); MAHANGARE Sachin Jaysing (IN); VIDHATE Prashant Popatrao (IN); LAGAD Dipak Raychand (IN) et TARAGE Anand Jagannath (IN). (73) Lupin Limited, Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), MUMBAI 400 055 (IN) (74) Cabinet ÉKÉMÉ Lysaght SARL, B.P. 6370, YAOUNDE (CM). (57) Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof, (formula I) wherein R1-R4, and n are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt thereof, and methods of treating or preventing diseases or disorders, for example, cancer, that are amenable to treatment or prevention by inhibiting the PI3K enzyme of a subject. Formula I ________________________________________ (11) 21529 Consulter le mémoire (51) G06Q 10/00 (2018.01) (21) 1202300509 (22) 22/12/2023 (54) Le dispositif de collecte automatique et de suivi des finances communautaires et institutionnelles (Mendo-Coti). (72) NGBWA NGBWA Hugues Cédric (CM)
RkJQdWJsaXNoZXIy MTM1NDc3MA==